论文部分内容阅读
目的观察奥扎格雷钠联合低分子量肝素治疗急性脑梗死的临床疗效。方法将130例急性脑梗死患者随机分为两组:对照组65例采用血栓通注射液、肠溶阿司匹林、脑保护剂等治疗。治疗组65组在对照组基础上加用奥扎格雷钠80mg/d,加入生理盐水250ml静脉滴注,每天1次,连用14d,同时给予低分子量肝素针2500U皮下注射,每天2次,连用7d。结果治疗组临床显效率91.67%明显高于对照组63.33%。结论奥扎格雷钠联合低分子量肝素治疗急性脑梗死临床疗效显著,安全可行。
Objective To observe the clinical efficacy of sodium ozagrel combined with low molecular weight heparin in the treatment of acute cerebral infarction. Methods 130 patients with acute cerebral infarction were randomly divided into two groups: control group of 65 patients treated with Xueshuantong injection, enteric-coated aspirin, brain protective agent. In the treatment group, 65 patients were given Ozagrel sodium 80mg / d on the basis of the control group, 250ml of normal saline was added intravenously once daily for 14 days, then given low molecular weight heparin needle 2,500U subcutaneously twice a day for 7 days . Results The clinical effective rate was 91.67% in the treatment group was significantly higher than 63.33% in the control group. Conclusion Ozagrel sodium combined with low molecular weight heparin in the treatment of acute cerebral infarction has significant clinical efficacy and is safe and feasible.